Researchers and physician-scientists from the Harvard Medical School-led Massachusetts Consortium on Pathogen Readiness (MassCPR) and thought leaders will discuss the state of COVID-19 vaccine development, latest efforts, clinical trials underway, and others expected to launch soon.
Topics include:
• Vaccines and immunity; how vaccines trigger immune protection
• Vaccine platforms in development, research findings to date, strategies for vaccine acceleration, and vaccine scalability and distribution
• Equity and disparities in vaccine research
• Lessons learned from past vaccine successes and failures
Presenters:
George Q. Daley
Dean of the Faculty of Medicine, Harvard University
Lindsey Baden
Associate Professor of Medicine, Harvard Medical School
Director of Clinical Research, Brigham and Women’s Hospital
Dan Barouch
Professor of Medicine, Harvard Medical School
Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
Nicole Frahm
Exploratory Biomarker Leader, Bill & Melinda Gates Medical Research Institute
Affiliate Associate Member, Fred Hutchinson Cancer Research Center
Bisola Ojikutu
Assistant Professor of Medicine and of Global Health and Social Medicine, Harvard Medical School
Infectious Disease Specialist, Brigham and Women’s Hospital/Massachusetts General Hospital
Arlene Sharpe
Chair, Department of Immunology, Harvard Medical School
Co-director, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital
Bruce Walker
Professor of Medicine, Harvard Medical School
Director, Ragon Institute of MGH, MIT and Harvard
Director, Harvard University Center for AIDS Research
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
